Sponsored by
This drug is already approved for a different indication, so if this trial shows that it is useful for this patient population, we have easy access to it! Note that there are two "Connect" Consortiums. This one was the first to use that name, and is for pediatric brain tumors. The NCI Connect program handles 12 rare diseases in adults including brain tumors.